feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / New Hope for Glioblastoma: £2.6m Research Centre Opens

New Hope for Glioblastoma: £2.6m Research Centre Opens

13 Dec, 2025

•

Summary

  • A new £2.6m research centre at the University of Nottingham will fight glioblastoma.
  • The centre will use AI and advanced MRI to detect tumour recurrence earlier.
  • The initiative offers hope to patients like Verity Phillips and families like Cullen's.
New Hope for Glioblastoma: £2.6m Research Centre Opens

A significant investment of £2.6 million is establishing a new centre of excellence at the University of Nottingham, dedicated to advancing the understanding and treatment of glioblastoma. This ambitious project aims to find a cure for the most aggressive adult brain tumour, offering renewed hope to those affected.

The centre will leverage cutting-edge technologies, including artificial intelligence and advanced MRI imaging, to improve the early detection of tumour recurrence. Researchers envision a future where personalized drug therapies can be identified through brain imaging alone, specifically targeting glioblastoma recurrence in individual patients.

This development is being welcomed by families who have experienced the devastating impact of glioblastoma, such as Maggie Cullen, whose son Josh passed away from the disease. It also provides a beacon of hope for living patients like Verity Phillips, who are determined to raise awareness and support research until a cure is found.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
It is a new centre of excellence, funded with a £2.6m investment, focused on improving the understanding and treatment of glioblastoma.
The centre will use AI and advanced MRI imaging to detect tumour recurrence earlier and develop tailored treatments.
The research is supported by Brain Tumour Research charity, and welcomed by patients and families affected by glioblastoma.

Read more news on

Healthside-arrowArtificial Intelligence (AI)side-arrow
trending

Salt Lake City funeral shooting

trending

Roblox mandates age verification

trending

Warriors beat Bucks at home

trending

Amazon Prime settlement refunds

trending

Elle Simone Scott dies at 49

trending

Raptors beat Hornets at buzzer

trending

Hawks might trade Trae Young

trending

Gilgeous-Alexander questionable versus Jazz

trending

Magic beat Nets at buzzer

You may also like

India's First AI Clinic Opens Doors

4 Jan • 17 reads

article image

AI Headset Predicts Seizures Minutes Before They Hit

3 Jan • 26 reads

article image

AI Predicts Liposuction Blood Loss with 94% Accuracy

2 Jan • 28 reads

AI to Unlock 3D Black Hole Movies

19 Dec, 2025 • 94 reads

article image

AI Consciousness: Are We Ready for the Unknown?

18 Dec, 2025 • 162 reads

article image